Return to QS3 Overview

VTE Prophylaxis [QS3]

Measuring the use of this guidance

Statement: 1

All patients, on admission, receive an assessment of VTE and bleeding risk using the clinical risk assessment criteria described in the national tool.

Quality standard measure: Proportion of patients assessed on admission for VTE and bleeding risk using the clinical risk assessment criteria described in the national tool.
What was measured: Proportion of adult hospital admissions assessed for risk of VTE on admission.
Data collection end: September 2010
53%
Data collection end: December 2010
68%
Data collection end: March 2011
81%
Data collection end: June 2011
84%
Data collection end: September 2011
88%
Data collection end: December 2011
91%
Data collection end: March 2012
93%
Data collection end: June 2012
93%
Data collection end: September 2012
94%
Data collection end: December 2012
94%
Data collection end: March 2013
94%
Data collection end: June 2013
95%
Data collection end: September 2013
96%
Data collection end: December 2013
96%
Data collection end: March 2014
96%
Data collection end: June 2014
96%
Data collection end: September 2014
96%
Data collection end: December 2014
96%
Data collection end: March 2015
96%
Data collection end: June 2015
96%
Data collection end: March 2016
96%
Area covered: England
Source: NHS England VTE Risk Assessment Data Collection

Quality standard measure: Proportion of patients assessed on admission for VTE and bleeding risk using the clinical risk assessment criteria described in the national tool.
What was measured: Proportion of adult hospital admissions assessed for risk of VTE on admission.
Data collection end: June 2016
95.7%
Number that met the criteria: 3550118 / 3708198
Area covered: England
Source: NHS England VTE Risk Assessment Data Collection


Statement: 2

Patients/carers are offered verbal and written information on VTE prevention as part of the admission process.

Quality standard measure: Proportion of patients/carers who are offered verbal and written information on VTE prevention as part of the admission process.
What was measured: Trusts who provide verbal and / or written information to patients about VTE prevention as part of admisson and discharge process AND were able to provide audit information to validate this claim
Data collection end: March 2012
12%
Data collection end: March 2013
28%
Area covered: National
Source: All Party Parliamentary Thrombosis Group Report

Quality standard measure: Proportion of patients/carers who are offered verbal and written information on VTE prevention as part of the admission process.
What was measured: Proportion of Trusts that produce and disseminate their own patient information leaflets on VTE prevention.
Data collection end: March 2016
77%
Area covered: National
Source: All Party Parliamentary Thrombosis Group Report


Statement: 5

Patients assessed to be at risk of VTE are offered VTE prophylaxis in accordance with NICE guidance.

Quality standard measure: Proportion of patients assessed to be at increased risk of VTE who are offered VTE prophylaxis in accordance with NICE guidance.
What was measured: Trusts who audit whether VTE prescriptions are in line with the recommendations and who can provide audit data for the previous financial year to validate this claim
Data collection end: March 2012
58%
Area covered: National
Source: All Party Parliamentary Thrombosis Group Report

Quality standard measure: Proportion of patients assessed to be at increased risk of VTE who are offered VTE prophylaxis in accordance with NICE guidance.
What was measured: Trusts who have in place a written policy for VTE prevention that is in line with all seven Quality Statements
Data collection end: March 2012
82%
Data collection end: March 2013
78%
Area covered: National
Source: All Party Parliamentary Thrombosis Group Report

Quality standard measure: Proportion of patients assessed to be at increased risk of VTE who are offered VTE prophylaxis in accordance with NICE guidance.
What was measured: Trusts who have in place a written policy for VTE prevention that is in line with all seven Quality Statements.
Data collection end: March 2016
92%
Area covered: National
Source: All Party Parliamentary Thrombosis Group Report



 Return to QS3 Overview